Eric Schadt Insider Profile
4 Followers
Eric Schadt, President & Chief R&D Officer, Director at GeneDx Holdings, holds 243.38K shares in GeneDx Holdings (Ticker: WGS). Most recently, Eric Schadt Bought 100,000 shares of GeneDx Holdings on May 24, 2022 for an estimated value of $192.00K.
Eric Schadt's Trading History
| WGSGeneDx Holdings | May 24, 2022 | President & Chief R&D Officer, Director | Informative Buy | 192.00K | $12.75M | |
WGS Insider Shares: 243.38K (0.06%) | ||||||
You May Also Like
Eric Schadt insider profile FAQ
What is the percentage of profitable transactions made by Eric Schadt?
The percentage of profitable transactions made by Eric Schadt is 67%.
What is the average return per transaction made by Eric Schadt?
The average return per transaction made by Eric Schadt is -5.30%.
What stocks does Eric Schadt hold?
Eric Schadt holds: WGS stocks.
What was Eric Schadt’s latest transaction?
Eric Schadt’s latest transaction was an Informative Buy of $192.00K.
What was Eric Schadt's most profitable transaction?
Eric Schadt’s most profitable transaction was an Informative Sell of WGS stock on February 2, 2022. The return on the trade was 48.10%.
What is Eric Schadt's role in GeneDx Holdings?
Eric Schadt's role in GeneDx Holdings is President & Chief R&D Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
